-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QEswy9r4ZMMAEBKOAMTXJoasz9Le2NiBxkaRrxro/RDbKCIZ+UPjg9WAzLVLUUuJ 57T9LFFXxmGoo9cpKQ0bUQ== 0001275287-05-002461.txt : 20050708 0001275287-05-002461.hdr.sgml : 20050708 20050708160740 ACCESSION NUMBER: 0001275287-05-002461 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050708 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050708 DATE AS OF CHANGE: 20050708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHOTOMEDEX INC CENTRAL INDEX KEY: 0000711665 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 592858100 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11635 FILM NUMBER: 05945999 BUSINESS ADDRESS: STREET 1: 147 KEYSTONE DRIVE CITY: MONTGOMERYVILLE STATE: PA ZIP: 18936 BUSINESS PHONE: 2156193600 MAIL ADDRESS: STREET 1: 147 KEYSTONE DRIVE CITY: MONTGOMERYVILLE STATE: PA ZIP: 18936 FORMER COMPANY: FORMER CONFORMED NAME: LASER PHOTONICS INC DATE OF NAME CHANGE: 19920703 8-K 1 pi3044.txt ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 8, 2005 ------------------------------------------------ Date of Report (Date of earliest event reported) PhotoMedex, Inc. ------------------------------------------------------ (Exact name of Registrant as specified in its charter) Delaware 0-11635 59-2058100 ------------------------------ ------------ ------------------- (State or other (Commission (I.R.S. Employer jurisdiction of incorporation) File Number) Identification No.) 147 Keystone Drive, Montgomeryville, Pennsylvania 18936 ------------------------------------------------------- (Address of principal executive offices) (Zip Code) (215) 619-3600 -------------------------------------------------- Registrant's telephone number, including area code Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ================================================================================ ITEM 8.01 OTHER EVENT On July 7, 2005, PhotoMedex, Inc. issued a press release which is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The press release announced that United Healthcare, a leading healthcare provider serving more than 18 million individual customers worldwide, had adopted a medical policy covering medically necessary treatment of mild to moderate psoriasis using the PhotoMedex XTRAC(R) laser system. The policy decision was effective as of June 21, 2005 and includes Oxford Health Plans. The information set forth under "Item 8.01, Other Event", including the accompanying Exhibit 99.1, is being furnished in accordance with interim guidance issued by the Securities and Exchange Commission in Release No. 33-8216. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information in this report, including the exhibit hereto, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended or be otherwise subject to the liabilities of that section or Sections 11 and 12 (a) (2) of the Securities Act of 1933, as amended. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (C) EXHIBITS. 99.1 Press Release, dated July 7, 2005. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. PHOTOMEDEX, INC. Dated: July 8, 2005 By: /s/Jeffrey F. O'Donnell ----------------------- Jeffrey F. O'Donnell Chief Executive Officer 3 EXHIBIT INDEX Exhibit Number Description - -------------- -------------------------------------------------------------- 99.1 Press release, dated July 7, 2005, regarding the announcement of the favorable policy decision from United Healthcare for the PhotoMedex XTRAC(R). 4 EX-99.1 2 pi3044ex991.txt Exhibit 99.1 PHOTOMEDEX XTRAC(R) RECEIVES FAVORABLE POLICY DECISION FROM UNITEDHEALTHCARE MONTGOMERYVILLE, Pa., July 7 /PRNewswire-FirstCall/ -- PhotoMedex, Inc. (Nasdaq: PHMD) today announced that UnitedHealthcare, a leading healthcare provider serving more than 18 million individual customers around the world, has adopted a medical policy covering medically necessary treatment of mild to moderate psoriasis using the PhotoMedex XTRAC(R) laser system. UnitedHealthcare is a part of UnitedHealth Group, a diversified Fortune 100 company. The policy decision was effective as of June 21, 2005 and includes Oxford Health Plans, as well, which was recently acquired by UnitedHealthcare. Jeff O'Donnell, CEO of PhotoMedex, said, "The adoption of a policy by UnitedHealthcare approving the treatment of mild to moderate psoriasis with our XTRAC laser is a milestone for our Company and we believe great news for the millions of people around the country who suffer from psoriasis. For PhotoMedex, insurance reimbursement is an important business driver as it provides physicians and patients with a clinically proven and effective treatment for their disease management. It is our understanding that UnitedHealthcare performed an extensive technology assessment that included input from the American Academy of Dermatology and the National Psoriasis Foundation as well as from independent technology rating organizations in arriving at their decision to consider XTRAC treatments as a proven benefit. This review of the XTRAC adds to those performed by all of the other national insurers and many regional managed care organizations underscoring the value of our laser system to psoriasis sufferers. We look forward to being able to provide the XTRAC treatment to UnitedHealthcare members and to continuing our work to make the XTRAC a covered benefit by all insurance companies." Continuing, O'Donnell added: "The adoption of a policy by UnitedHealthcare and Oxford adds to previously announced decisions from Aetna, Cigna, the Blue Cross Blue Shield Plans of WellPoint, Anthem, Carefirst, Regence and other individual Blue Cross Blue Shield Plans in many states and many other private insurers." UnitedHealthcare, along with its sister company Uniprise Solutions, provides access to high-quality care from more than 470,000 physicians and 4,500 hospitals across all 50 states and in four international markets. Member physicians can access the medical policy covering the XTRAC(R) at www.uhc.com. About PhotoMedex: PhotoMedex provides contract medical procedures to hospitals, surgi-centers and doctors' offices, offering a wide range of products and services across multiple specialty areas, including dermatology, urology, gynecology, orthopedics, and other surgical specialties. The Company is a leader in the development, manufacturing and marketing of medical laser products and services. In addition as a result of the merger with ProCyte, PhotoMedex now develops and markets products based on its patented, clinically proven Copper Peptide technology for skin health, hair care and wound care. The Company sells directly to dermatologists, plastic and cosmetic surgeons, spas and salons and through licenses with strategic partners into the consumer market, including a long-term worldwide license agreement with Neutrogena(R), a Johnson & Johnson company. ProCyte brands include Neova(R), Ti-Silc(R), VitalCopper(R), Simple Solutions(R) and AquaSante(R). Some portions of the press release, will contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While PhotoMedex is working to achieve those goals, actual results could differ materially from those projected in the forward-looking statements as a result of a number of factors, including difficulties in marketing its products and services, need for capital, competition from other companies and other factors, any of which could have an adverse effect on the business plans of PhotoMedex, its reputation in the industry or its results. In light of significant uncertainties inherent in forward-looking statements included herein, the inclusion of such information in the press release should not be regarded as a representation by PhotoMedex or its subsidiaries that the forward looking statements will be achieved. Contact: Allen & Caron PhotoMedex, Inc. Matt Clawson (investors) Dennis McGrath, CFO 949-474-4300 215-619-3287 matt@allencaron.com info@photomedex.com SOURCE PhotoMedex, Inc. -0- 07/07/2005 /CONTACT: Dennis McGrath, CFO, PhotoMedex, Inc., +1-215-619-3287, info@photomedex.com; or Matt Clawson, Investors, +1-949-474-4300, matt@allencaron.com, for PhotoMedex, Inc./ /Web site: http://www.uhc.com / -----END PRIVACY-ENHANCED MESSAGE-----